TR200000419T2 - Feksofenadin ve türevlerinin biyo elde edilebilirliklerinin arttırılması yöntemi. - Google Patents
Feksofenadin ve türevlerinin biyo elde edilebilirliklerinin arttırılması yöntemi.Info
- Publication number
- TR200000419T2 TR200000419T2 TR2000/00419T TR200000419T TR200000419T2 TR 200000419 T2 TR200000419 T2 TR 200000419T2 TR 2000/00419 T TR2000/00419 T TR 2000/00419T TR 200000419 T TR200000419 T TR 200000419T TR 200000419 T2 TR200000419 T2 TR 200000419T2
- Authority
- TR
- Turkey
- Prior art keywords
- bioavailability
- fexofenadine
- derivatives
- increasing
- patient
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- RWTNPBWLLIMQHL-UHFFFAOYSA-N fexofenadine Chemical compound C1=CC(C(C)(C(O)=O)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 RWTNPBWLLIMQHL-UHFFFAOYSA-N 0.000 title 1
- 229960003592 fexofenadine Drugs 0.000 title 1
- 229940049937 Pgp inhibitor Drugs 0.000 abstract 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 abstract 1
- 230000001387 anti-histamine Effects 0.000 abstract 1
- 239000000739 antihistaminic agent Substances 0.000 abstract 1
- 238000011260 co-administration Methods 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 239000002748 glycoprotein P inhibitor Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/745—Polymers of hydrocarbons
- A61K31/75—Polymers of hydrocarbons of ethene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A61K31/77—Polymers containing oxygen of oxiranes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US91156397A | 1997-08-14 | 1997-08-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR200000419T2 true TR200000419T2 (tr) | 2000-09-21 |
Family
ID=25430473
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2000/00419T TR200000419T2 (tr) | 1997-08-14 | 1998-07-21 | Feksofenadin ve türevlerinin biyo elde edilebilirliklerinin arttırılması yöntemi. |
Country Status (29)
| Country | Link |
|---|---|
| EP (1) | EP1003528B1 (enExample) |
| JP (1) | JP4295913B2 (enExample) |
| KR (1) | KR100522985B1 (enExample) |
| CN (1) | CN1143680C (enExample) |
| AR (1) | AR018505A1 (enExample) |
| AT (1) | ATE224721T1 (enExample) |
| AU (1) | AU725965C (enExample) |
| BR (1) | BR9811937A (enExample) |
| CA (1) | CA2301267C (enExample) |
| CZ (1) | CZ293666B6 (enExample) |
| DE (1) | DE69808303T2 (enExample) |
| DK (1) | DK1003528T3 (enExample) |
| EE (1) | EE04263B1 (enExample) |
| ES (1) | ES2179523T3 (enExample) |
| HU (1) | HU226823B1 (enExample) |
| ID (1) | ID24463A (enExample) |
| IL (1) | IL134521A (enExample) |
| NO (1) | NO325148B1 (enExample) |
| NZ (1) | NZ502133A (enExample) |
| OA (1) | OA11287A (enExample) |
| PL (1) | PL191607B1 (enExample) |
| PT (1) | PT1003528E (enExample) |
| RU (1) | RU2197967C2 (enExample) |
| SK (1) | SK283868B6 (enExample) |
| TR (1) | TR200000419T2 (enExample) |
| TW (1) | TWI240633B (enExample) |
| UA (1) | UA64765C2 (enExample) |
| WO (1) | WO1999008690A1 (enExample) |
| ZA (1) | ZA987221B (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69624559T2 (de) | 1995-02-28 | 2003-07-10 | Aventis Pharmaceuticals Inc., Bridgewater | Arzneizubereitungen für piperidinalkanolderivate |
| EP0998272B1 (en) * | 1997-08-26 | 2003-05-02 | Aventis Pharmaceuticals Inc. | Pharmaceutical composition for combination of piperidinoalkanol-decongestant |
| GB9822170D0 (en) * | 1998-10-13 | 1998-12-02 | Danbioyst Uk Ltd | Novel formulations of fexofenadine |
| WO2003101437A2 (en) * | 2002-05-29 | 2003-12-11 | Aventis Pharmaceuticals Holdings Inc. | Method of treating asthma using fexofenadine |
| GB0319935D0 (en) * | 2003-08-26 | 2003-09-24 | Cipla Ltd | Polymorphs |
| PE20060416A1 (es) * | 2004-08-03 | 2006-06-09 | Novartis Ag | Composicion de inhibidores de renina e inhibidores de proteinas de efusion |
| JP2008120684A (ja) * | 2005-03-07 | 2008-05-29 | Kumamoto Univ | 抗アレルギー薬 |
| KR101106374B1 (ko) | 2009-06-05 | 2012-01-19 | 민병욱 | 고체연료에 의한 가연성 가스 발생 장치 |
| KR101117014B1 (ko) * | 2009-09-09 | 2012-06-14 | 민병욱 | 부패성 폐기물의 바이오매스 처리에 의한 폐자원 재활용 방법 및 장치 |
| CN101843616B (zh) * | 2010-06-04 | 2011-07-27 | 西安万隆制药有限责任公司 | 一种盐酸非索非那定与微晶纤维素组合物及其制备方法 |
| RU2453315C2 (ru) * | 2010-08-17 | 2012-06-20 | Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") | Фармацевтическая композиция для лечения аллергических заболеваний |
| EA201391742A1 (ru) | 2011-05-20 | 2014-04-30 | Авентис Фармасьютикалз Инк. | Фармацевтическая композиция, включающая фексофенадин |
| RU2504018C1 (ru) * | 2012-05-28 | 2014-01-10 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Рязанский государственный медицинский университет имени академика И.П. Павлова" Министерства здравоохранения и социального развития Российской Федерации | Способ моделирования состояния индукции функциональной активности гликопротеина-р финастеридом в эксперименте |
| RU2553362C1 (ru) * | 2014-01-09 | 2015-06-10 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Рязанский государственный медицинский университет имени академика И.П. Павлова" Министерства здравоохранения Российской Федерации | Способ моделирования состояния ингибирования функциональной активности гликопротеина-р линестренолом в эксперименте |
| CN104188998A (zh) * | 2014-09-18 | 2014-12-10 | 中山大学 | 一种柚皮苷与盐酸非索非那丁药物组合物及其制剂 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4254129A (en) * | 1979-04-10 | 1981-03-03 | Richardson-Merrell Inc. | Piperidine derivatives |
| NO900427L (no) * | 1989-01-31 | 1990-08-01 | Int Pharma Agentur | Erosjonsregulert frigjoeringssystem for aktive stoffer og en fremgangsmaate for deres fremstilling. |
| US5567592A (en) * | 1994-02-02 | 1996-10-22 | Regents Of The University Of California | Screening method for the identification of bioenhancers through the inhibition of P-glycoprotein transport in the gut of a mammal |
| CA2224227A1 (en) * | 1995-06-07 | 1996-12-19 | Avmax, Inc. | Use of essential oils to increase bioavailability of oral pharmaceutical compounds |
| AU5893796A (en) * | 1995-06-07 | 1996-12-30 | Novo Nordisk A/S | Modification of polypeptides |
-
1998
- 1998-07-21 DK DK98935892T patent/DK1003528T3/da active
- 1998-07-21 ES ES98935892T patent/ES2179523T3/es not_active Expired - Lifetime
- 1998-07-21 EE EEP200000069A patent/EE04263B1/xx unknown
- 1998-07-21 SK SK184-2000A patent/SK283868B6/sk not_active IP Right Cessation
- 1998-07-21 IL IL13452198A patent/IL134521A/xx not_active IP Right Cessation
- 1998-07-21 DE DE69808303T patent/DE69808303T2/de not_active Expired - Lifetime
- 1998-07-21 EP EP98935892A patent/EP1003528B1/en not_active Expired - Lifetime
- 1998-07-21 BR BR9811937-0A patent/BR9811937A/pt not_active Application Discontinuation
- 1998-07-21 CN CNB988081598A patent/CN1143680C/zh not_active Expired - Lifetime
- 1998-07-21 RU RU2000106042/14A patent/RU2197967C2/ru active
- 1998-07-21 AT AT98935892T patent/ATE224721T1/de active
- 1998-07-21 CA CA002301267A patent/CA2301267C/en not_active Expired - Lifetime
- 1998-07-21 PT PT98935892T patent/PT1003528E/pt unknown
- 1998-07-21 UA UA2000031425A patent/UA64765C2/uk unknown
- 1998-07-21 HU HU0003189A patent/HU226823B1/hu unknown
- 1998-07-21 JP JP2000509429A patent/JP4295913B2/ja not_active Expired - Lifetime
- 1998-07-21 WO PCT/US1998/015098 patent/WO1999008690A1/en not_active Ceased
- 1998-07-21 KR KR10-2000-7001447A patent/KR100522985B1/ko not_active Expired - Lifetime
- 1998-07-21 AU AU85050/98A patent/AU725965C/en not_active Expired
- 1998-07-21 PL PL338579A patent/PL191607B1/pl unknown
- 1998-07-21 NZ NZ502133A patent/NZ502133A/xx not_active IP Right Cessation
- 1998-07-21 TR TR2000/00419T patent/TR200000419T2/xx unknown
- 1998-07-21 ID IDW20000262A patent/ID24463A/id unknown
- 1998-07-21 CZ CZ2000522A patent/CZ293666B6/cs not_active IP Right Cessation
- 1998-08-12 ZA ZA987221A patent/ZA987221B/xx unknown
- 1998-08-13 AR ARP980104005A patent/AR018505A1/es active IP Right Grant
- 1998-11-05 TW TW087113210A patent/TWI240633B/zh not_active IP Right Cessation
-
2000
- 2000-02-09 OA OA1200000032A patent/OA11287A/en unknown
- 2000-02-11 NO NO20000706A patent/NO325148B1/no not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR200200205T2 (tr) | MEK inhibitörleri kullanılarak kronik ağrının tedavi edilmesi | |
| EE200100492A (et) | Ensüümi IMPDH inhibiitorid | |
| PT1002795E (pt) | Pirimidinas inibidoras da replicacao do hiv | |
| SE9703693D0 (sv) | Novel combination | |
| ID22982A (id) | PIRAZOL-PIRAZOL TERSUBSTITUSI SEBAGAI INHIBITOR KINASE p38 | |
| EE200000488A (et) | Fosfolipaasensüümide inhibiitorid ja farmatseutilised kompositsioonid | |
| DE60002193D1 (de) | Metalloprotease inhibitoren | |
| DK1133477T3 (da) | Substituerede benzimidazoler og deres anvendelse som parpinhibitorer | |
| DK1268481T3 (da) | Inaseinkibitorer som terapeutiske midler | |
| NO20031843D0 (no) | Metylfenidatmodifiserte frigjöringspreparater | |
| ATE234091T1 (de) | Thrombin inhibitoren | |
| TR199903287T2 (xx) | Matriks metaloproteinazlar�n�n ters hidroksamat inhibit�rleri. | |
| TR200502508T2 (tr) | IL-18 İnhibitörlerinin kullanımı. | |
| LU91345I2 (fr) | Rufinamide et ses sels pharmaceutiquement acceptables (inovelon) | |
| ATE429224T1 (de) | Arzneizubereitungen enthaltend mindestens einen hiv preoteaseinhibitor | |
| NO20015897D0 (no) | Indolylpiperidinderivater som antihistaminiske og antiallergiske midler | |
| NO20014243D0 (no) | Dihetero-substituerte metalloprotease inhibitorer | |
| CA2301267A1 (en) | Method of enhancing bioavailability of fexofenadine and its derivatives | |
| ATE228760T1 (de) | Thrombininhibitoren | |
| DK1214302T3 (da) | Substituerede 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-oner og deres anvendelse som lipasehæmmere | |
| DE60024101D1 (de) | Enzyminhibitoren | |
| ITBO990293A0 (it) | Metodo di controllo di banconote . | |
| FI20011649L (fi) | Korkeapaineinen, suurnopeuksinen primäärinen ja sekundäärinen jalostus | |
| TR199800847A3 (tr) | Bir anjiyotensin dönüstürücü enzim inhibitörünün sabit doz bilesimi. | |
| ID24224A (id) | Turunan-turunan 6-azaurasil sebagai inhibitor il-5 |